A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Vice President Strategic Planning

Corporate StrategyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$332k - $448kIn-person

About the Job

Requirements

  • An advanced degree (MBA or equivalent) is strongly preferred, with 15 or more years of progressive leadership experience in strategic planning, corporate strategy, management consulting, finance, business operations, or related fields.
  • Demonstrated success leading enterprise-wide strategic initiatives, transformations, or portfolio management efforts within complex global organizations.
  • Ability to influence executive leaders and drive decision-making across highly matrixed environments.
  • At least 5 years of experience in senior operating roles within industry.
  • Strong business, financial, and strategic acumen, with a track record of translating strategy into measurable business results.
  • Experience supporting executive leadership teams and participating in board-level or enterprise governance discussions is preferred.
  • Biopharmaceutical, biotechnology, healthcare, or similarly complex industry experience is preferred.
  • Thinks broadly across the organization and balances short-term priorities with long-term strategic objectives.
  • Builds alignment among senior stakeholders and effectively navigates competing priorities.
  • Communicates with confidence and credibility at executive, board, and organizational levels.
  • Operates effectively in complex, rapidly evolving environments and drives alignment amid ambiguity.
  • Integrates financial, operational, and strategic considerations into decision-making.
  • Drives accountability and execution excellence while maintaining focus on enterprise outcomes.
  • Develops trusted partnerships and fosters productive cross-functional engagement.

Responsibilities

  • Lead the enterprise Alignment, Timing & Coordination (ATC) framework to ensure successful execution of Alnylam's strategic priorities and long-range objectives.
  • Partner with the Executive Leadership Team to drive alignment on enterprise priorities, resource allocation, sequencing decisions, and strategic trade-offs.
  • Provide enterprise-level visibility across the strategic initiative portfolio, including progress, dependencies, risks, resource demands, and organizational impact.
  • Anticipate emerging business risks, organizational capacity constraints, and execution challenges, and proactively recommend mitigation strategies and executive actions.
  • Lead enterprise governance processes, including executive reviews, portfolio prioritization, strategic performance monitoring, and decision-making forums.
  • Drive organizational alignment and transparency through executive communications, governance forums, and enterprise-wide engagement strategies.
  • Lead enterprise discussions about prioritization, sequencing, resource allocation, execution capacity, and organizational readiness across strategic initiatives; identify interdependencies, competing priorities, timing conflicts, and capacity constraints affecting the strategic portfolio.
  • Recommend portfolio-level trade-offs and coordination approaches that optimize enterprise effectiveness and support strategic objectives.
  • Partner with initiative sponsors and leaders to ensure alignment with enterprise priorities, governance expectations, and approved resource plans.
  • Develop frameworks and reporting that provide leadership with consistent visibility into initiative demand, portfolio health, and organizational capacity.
  • Translate enterprise strategy into actionable operating priorities, multi-year roadmaps, and measurable business outcomes.
  • Partner across Finance, Commercial, R&D, Technical Operations, Corporate Functions, and other stakeholders to integrate strategic initiatives into planning and resource allocation processes.
  • Lead development of executive-level analyses, strategic recommendations, investment frameworks, and business cases to inform enterprise decisions.
  • Monitor enterprise performance and strategic initiative outcomes, identifying opportunities to optimize execution, resource deployment, and organizational effectiveness.
  • Provide thought leadership on emerging trends, market dynamics, and organizational capabilities that may affect strategic objectives.
  • Serve as a key member of the Financial & Strategic Planning Leadership Team, contributing to the function's direction, strategy, and operating model.
  • Act as a trusted advisor to senior leaders, providing strategic counsel and objective perspectives on complex business issues.
  • Foster accountability, collaboration, transparency, and operational excellence across enterprise initiatives.
  • Build and leverage cross-functional partnerships to influence outcomes and drive organizational alignment.
  • Lead through influence across matrixed teams and senior stakeholders to ensure successful delivery of enterprise priorities.
  • Develop organizational capabilities, planning processes, and governance mechanisms that strengthen the company's ability to execute strategy at scale.
  • Provide strategic input on enterprise projects.
  • Support Strategic Planning projects, including annual goal setting and measurement, and decision analytics and support.
  • Build organizational capabilities in strategic planning, portfolio governance, enterprise prioritization, and resource alignment.
  • Develop scalable planning and governance processes that support increasing organizational complexity.
  • Provide staff augmentation on major initiative startup.
  • Oversee and integrate short-term external consulting projects.

Desired Qualifications

  • An advanced degree (MBA or equivalent) is strongly preferred.
  • Experience supporting executive leadership teams and participating in board-level or enterprise governance discussions is preferred.
  • Biopharmaceutical, biotechnology, healthcare, or similarly complex industry experience is preferred.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs